These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11555892)

  • 1. [Duchenne muscular dystrophy].
    Ishihara T
    Ryoikibetsu Shokogun Shirizu; 2001; (35):14-7. PubMed ID: 11555892
    [No Abstract]   [Full Text] [Related]  

  • 2. [Becker muscular dystrophy].
    Ishihara T
    Ryoikibetsu Shokogun Shirizu; 2001; (35):18-22. PubMed ID: 11555904
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of intermittent positive pressure ventilation on life-span and causes of death in Duchenne muscular dystrophy].
    Konagaya M; Sakai M; Wakayama T; Kimura S; Kuru S; Yasuma F
    Rinsho Shinkeigaku; 2005 Sep; 45(9):643-6. PubMed ID: 16248395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18 years experience with mechanical ventilation in patients with Duchenne muscular dystrophy].
    Meinesz AF; Bladder G; Goorhuis JF; Fock JM; Staal-Schreinemachers AL; Zijlstra JG; Wijkstra PJ
    Ned Tijdschr Geneeskd; 2007 Aug; 151(33):1830-3. PubMed ID: 17874640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies for Duchenne and Becker dystrophies.
    Voisin V; de la Porte S
    Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Don't stop me now!].
    Wolf A; Schaack J; Freikamp L; Reutzel S; Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2008; 37(5):356-7. PubMed ID: 18729286
    [No Abstract]   [Full Text] [Related]  

  • 7. Myodys, a full-length dystrophin plasmid vector for Duchenne and Becker muscular dystrophy gene therapy.
    Duan D
    Curr Opin Mol Ther; 2008 Feb; 10(1):86-94. PubMed ID: 18228186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.
    Harper SQ; Hauser MA; DelloRusso C; Duan D; Crawford RW; Phelps SF; Harper HA; Robinson AS; Engelhardt JF; Brooks SV; Chamberlain JS
    Nat Med; 2002 Mar; 8(3):253-61. PubMed ID: 11875496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The silent yet successful revolution of mechanical ventilation in patients with neuromuscular disorders, in particular Duchenne muscular dystrophy].
    van Engelen BG
    Ned Tijdschr Geneeskd; 2007 Aug; 151(33):1817-8. PubMed ID: 17874636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shrinking genes for therapy.
    Bonetta L
    Nat Med; 2002 Mar; 8(3):222. PubMed ID: 11875490
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of therapy for Duchenne muscular dystrophy.
    Zhang S; Xie H; Zhou G; Yang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):194-203. PubMed ID: 17357471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.
    Bourke JP
    Dev Med Child Neurol; 2006 Mar; 48(3):164. PubMed ID: 16483389
    [No Abstract]   [Full Text] [Related]  

  • 13. The future of Duchenne muscular dystrophy gene therapy: shrinking the dystrophin gene.
    Roberts M; Dickson G
    Curr Opin Mol Ther; 2002 Aug; 4(4):343-8. PubMed ID: 12222872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duchenne and Becker muscular dystrophy: from gene diagnosis to molecular therapy.
    Matsuo M
    IUBMB Life; 2002 Mar; 53(3):147-52. PubMed ID: 12102170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient and fast functional screening of microdystrophin constructs in vivo and in vitro for therapy of duchenne muscular dystrophy.
    Jørgensen LH; Larochelle N; Orlopp K; Dunant P; Dudley RW; Stucka R; Thirion C; Walter MC; Laval SH; Lochmüller H
    Hum Gene Ther; 2009 Jun; 20(6):641-50. PubMed ID: 19239382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Duchenne muscular dystrophy gene therapy.
    van Deutekom JC; van Ommen GJ
    Nat Rev Genet; 2003 Oct; 4(10):774-83. PubMed ID: 14526374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy: the 'pro-sense' approach to Duchenne muscular dystrophy.
    van Deutekom JC
    Eur J Hum Genet; 2005 May; 13(5):518-9. PubMed ID: 15714219
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiopulmonary failure in Duchenne muscular dystrophy--pathophysiology and management].
    Ishihara T
    Rinsho Shinkeigaku; 2003 Nov; 43(11):761-4. PubMed ID: 15152458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.
    Wang B; Li J; Fu FH; Xiao X
    J Orthop Res; 2009 Apr; 27(4):421-6. PubMed ID: 18973234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 2009 perspective on the 2004 American Thoracic Society statement, "respiratory care of the patient with Duchenne muscular dystrophy".
    Finder JD
    Pediatrics; 2009 May; 123 Suppl 4():S239-41. PubMed ID: 19420152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.